Absci and caltech join forces, bolstered by major grant, to accelerate affordable hiv therapeutic vaccine development

Vancouver, wash., aug. 10, 2023 (globe newswire) -- absci corporation (nasdaq: absi ), a generative ai drug creation company, today announced that leading researchers at the california institute of technology (caltech) in conjunction with absci, a leader in ai drug creation, received a grant from the bill & melinda gates foundation. the grant supports the joint effort of caltech and absci to discover affordable hiv therapeutic vaccinations, with the goal of making a significant step forward in the fight against the global hiv/aids epidemic.
ABSI Ratings Summary
ABSI Quant Ranking